Literature DB >> 14268436

CLINICAL EXPERIENCE WITH N-HEXAMETHYLENE N'N'-DIETHYLENE THIOPHOSPHORAMIDE (KC-33), A NEW AGENT FOR BREAST AND OVARIAN CARCINOMA.

L E GOODMAN, D BAKAL, K C TSOU, S P KRAMER, A ULFOHN, S D GABY, H E DORFMAN, O AYBAR, E CENDANA, M G ASCOLI, A M SELIGMAN.   

Abstract

Entities:  

Keywords:  ANTINEOPLASTIC AGENTS; ASCITES; BREAST NEOPLASMS; CLINICAL RESEARCH; DRUG THERAPY; LUNG NEOPLASMS; MICE; NEOPLASM THERAPY; OVARIAN NEOPLASMS; PLEURAL EFFUSION; TOXICOLOGIC REPORT

Mesh：

Substances：

Year:  1965        PMID： 14268436     DOI： 10.1002/1097-0142(196503)18:3<307::aid-cncr2820180307>3.0.co;2-n

Source DB:  PubMed          Journal:  Cancer        ISSN： 0008-543X            Impact factor:   6.860


× No keyword cloud information.
  1 in total

1.  Enzyme alterable alkylating agents. 8. Clinical trials with intra-arterial infusion of an alkylating agent with a half-life of 0.2 second.

Authors:  L E Goodman; A Ulfohn; S P Kramer; E H Cendana; A B Flores; D Bakal; S J Abrams; R L Hirschfeld; S Calle; C E Williamson; S Sass; B Witten; A M Seligman
Journal:  Ann Surg       Date:  1965-10       Impact factor: 12.969
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.